Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04370600Phase 1Unknown
Phase 1, randomised, double-blind trial (2 arms), sponsored by Thomas Jefferson University. Primary endpoints: Blood Beta-Hydroxybutyrate Concentration at 1 year, Minutes at Maximum Exertion at 1 year and 5 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04370600.